A reminder that focus problems don’t always mean ADHD. That suffering doesn’t always need a label. And that quick relief can sometimes do lasting harm.
We use medications for reasons that don’t match their names. That’s why some clinicians are turning to Neuroscience-Based Nomenclature (NbN)—a system that classifies meds by mechanism instead of indication.
We reviewed Psymatik in The Carlat Psychiatry Report this month, as part of our occasional coverage on how AI and digital tools are changing the way we prescribe.